RxDoctor Payments Data

Arie Belldegrun

Urology · Los Angeles, CANPI 1013932847

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,779,968 of the $1,800,699 with a category attached, or 98.8%. Urogen Pharma, Inc. accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. Among urology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,800,699in general payments, 2019–2025

Across 68 payments — averaging $26,481 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Urogen Pharma, Inc.$1.8M
  • Rochester Medical Corporation$226
  • C. R. Bard, Inc. & Subsidiaries$26

What the payments were for

  • Speaking & faculty fees$1,779,96899%
  • Travel & lodging$18,6481%
  • Food & beverage$2,0830%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Urogen Pharma, Inc.45$1,800,446
Rochester Medical Corporation22$226
C. R. Bard, Inc. & Subsidiaries1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,800,699 in reported general payments places this provider in the 95th percentile of 1,324 urology providers in California.

See all urology providers in California

Other urology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →